Correlia Biosystems is a UC Berkeley spinoff company based out of the QB3@953 startup incubator in San Francisco. Correlia develops innovative microscale tools that accelerate the rate of molecular interactions for rapid measurements of biomolecules. Our versatile "SimpleScan"​ technology opens up new biological questions from less than two microliters of sample, with rapid results that allow for dynamic monitoring of protein expression profiles (rather than simple end-point measurement). Applications range from enabling next-gen proteomic data sets to point-of-care diagnostics.